UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid

Clinical cancer research, 2012-09, Vol.18 (17), p.4841-4849

2012

Link zum Volltext

Verfügbarkeit prüfen

Harnessing the potential of therapeutic agents to safeguard bone health in prostate cancer

Prostate cancer and prostatic diseases, 2018-11, Vol.21 (4), p.461-472

2018

Link zum Volltext

Verfügbarkeit prüfen

Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial

BMC cancer, 2011-08, Vol.11 (1), p.373-373, Article 373

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer

Journal of clinical oncology, 2009-02, Vol.27 (4), p.526-534

2009

Link zum Volltext

Verfügbarkeit prüfen

Monitoring of Serum Her-2/neu Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer

Clinical cancer research, 2004-03, Vol.10 (5), p.1618-1624

2004

Link zum Volltext

Verfügbarkeit prüfen

Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2012-2018

2007

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality

Heart (British Cardiac Society), 2015-12, Vol.101 (23), p.1874-1880

2015

Link zum Volltext

Verfügbarkeit prüfen

Tissue distribution of epirubicin after severe extravasation in humans

Cancer chemotherapy and pharmacology, 2021-08, Vol.88 (2), p.203-209

2021

Link zum Volltext

Verfügbarkeit prüfen

Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol

Supportive care in cancer, 2015-06, Vol.23 (6), p.1741-1748

2015

Link zum Volltext

Verfügbarkeit prüfen

Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro

Cancer letters, 2007-11, Vol.257 (1), p.73-78

2007

Link zum Volltext

Verfügbarkeit prüfen

Pegfilgrastim prophylaxis in patients at different levels of risk for chemotherapy-associated febrile neutropenia: an observational study

Current medical research and opinion, 2013-05, Vol.29 (5), p.505-515

2013

Link zum Volltext

Verfügbarkeit prüfen

Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy

Breast cancer research and treatment, 2003-03, Vol.78 (1), p.97-103

2003

Link zum Volltext

Verfügbarkeit prüfen

Indocyanine green video angiography predicts outcome of extravasation injuries

PloS one, 2014-08, Vol.9 (8), p.e103649-e103649

2014

Link zum Volltext

Verfügbarkeit prüfen

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna

ESMO open, 2016, Vol.1 (4), p.e000066-e000066, Article e000066

2016

Link zum Volltext

Verfügbarkeit prüfen

Exosomal microRNA transfer varies with specific microRNAs functional in colorectal cancer and cellular differentiation

International journal of clinical pharmacology and therapeutics, 2014-01, Vol.52 (1), p.87

2014

Link zum Volltext

Verfügbarkeit prüfen

NF-κB addiction and resistance to 5-fluorouracil in a multi-stage colon carcinoma model

International journal of clinical pharmacology and therapeutics, 2013-01, Vol.51 (1), p.35

2013

Link zum Volltext

Verfügbarkeit prüfen

microRNA expression profiles distinguish colorectal cancer patients in two regions of Austria

International journal of clinical pharmacology and therapeutics, 2014-01, Vol.52 (1), p.85

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(88)
Bücher
(1)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(66)
Humans
(65)
Female
(52)
Oncology
(52)
Biological And Medical Sciences
(44)
Medical Sciences
(43)
Middle Aged
(41)
Adult
(35)
Aged
(34)
Breast Neoplasms - Drug Therapy
(33)
Pharmacology. Drug Treatments
(28)
Chemotherapy
(26)
Breast Cancer
(25)
Antineoplastic Agents
(24)
Breast Neoplasms - Pathology
(22)
Tumors
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Male
(17)
Aged, 80 And Over
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial

Harnessing the potential of therapeutic agents to safeguard bone health in prostate cancer

Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast Cancer From the Austrian Breast and Colorectal Cancer Study Group

Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial

Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

Monitoring of Serum Her-2/neu Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer

Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14

Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality

Tissue distribution of epirubicin after severe extravasation in humans

Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol

The cancer survival index—A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies

Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro

Pegfilgrastim prophylaxis in patients at different levels of risk for chemotherapy-associated febrile neutropenia: an observational study

Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy

Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients

Indocyanine green video angiography predicts outcome of extravasation injuries

Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna

Exosomal microRNA transfer varies with specific microRNAs functional in colorectal cancer and cellular differentiation

NF-κB addiction and resistance to 5-fluorouracil in a multi-stage colon carcinoma model

microRNA expression profiles distinguish colorectal cancer patients in two regions of Austria

Suchergebnisse filtern